D-0495-2017 Class II Terminated
FDA drug recall D-0495-2017 was initiated by AbbVie Inc. on Jan 13, 2017 and is designated Class II. Reason for recall: Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of… The recall status is terminated (terminated Mar 15, 2019). Affected quantity: 4021 cartons, 7 100-mL cassettes each.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 8, 2017
- Initiation Date
- Jan 13, 2017
- Termination Date
- Mar 15, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4021 cartons, 7 100-mL cassettes each
Product description
Reason for recall
Distribution pattern
TN and IL
Code information
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0495-2017
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for AbbVie Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.